You are here

Community Foundation of New Jersey Announces New Board Member

Community Foundation of New Jersey Announces New Board Member

Monday, February 6, 2017

The Community Foundation of New Jersey (CFNJ) today announced that Ayo Sanderson, Executive Director & Head for the US Pharma Division of Novartis Pharmaceuticals Corporation, has joined its Board of Directors.

At Novartis, Sanderson leads the Advocacy and Alliance Development team. She began her career as a litigator with Lowenstein Sandler and subsequently joined the litigation department of Akin Gump in New York City. She later joined Bell Atlantic/Verizon serving as Executive Director and Regulatory Counsel and held legal and executive business leadership positions at T-Mobile USA. Most recently, Sanderson served as general counsel for a division of BAE Systems, Inc., a British-owned major defense contractor.

“Ayo’s experience in law, business, and the nonprofit sector is unmatched in its breadth,” said Tom Uhlman, Chairman of the CFNJ Board of Trustees. “Above all, she is rooted in community and has a passion for making neighborhoods across New Jersey better. We look forward to her lending her expertise to our Board and fundholders.”